Jump to navigation

Home

N4 Pharma

  • Home
  • About
    • Experienced Board
      • Nigel Theobald
      • Paul Titley
      • Dr David Templeton
      • Luke Cairns
    • Our business
    • Our history
    • Our model
  • Generics
  • Vaccines
    • Nuvac
    • Nuvec
  • Patents
  • Pipeline
    • Sildenafil
    • Sartans
    • Aprepitant
    • Single dose Hep B
    • Duoloxetine
    • Paroxetine
  • Investors
    • AIM Rule 26
      • AIM Securities information
      • Advisors
      • Corporate Governance and Director Responsibility
    • Investor Information
      • Company reports
    • Regulatory News
  • Contact Us
Back to top

  • Specialists in reformulation

    Across existing drugs and vaccine delivery to improve their performance

    Read more

  • History

    Established in 2014 and listed on the AIM market of the London Stock Exchange in May 2017

    Read more

  • Reformulation

    Focus on reformulation of already commercialised drugs and vaccine delivery

    Vaccines Generics

  • Current Pipeline

    The Company is engaged in a range of opportunities across both divisions

    Read more

Pipeline

A wide range of products backed by patent applications. Near term focus of the Company is on the following products/opportunities

Sildenafil

Erectile Dysfunction
Laboratory

Sartans

Anti-hypertensive

Aprepitant

Oncology and pain relief

Read more about our full Pipeline

Contact us for further information

Contact us

Copyright © 2017 N4 Pharma. All rights reserved.

Address: Weston house, Bradgate Park View, Chellaston, Derbyshire, DE73 5UJ
Email address: info@n4pharma.com

Privacy Policy | Terms and Conditions